These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23003111)

  • 1. Immunogenic characterization of outer membrane porins OmpC and OmpF of porcine extraintestinal pathogenic Escherichia coli.
    Liu C; Chen Z; Tan C; Liu W; Xu Z; Zhou R; Chen H
    FEMS Microbiol Lett; 2012 Dec; 337(2):104-11. PubMed ID: 23003111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli.
    Durant L; Metais A; Soulama-Mouze C; Genevard JM; Nassif X; Escaich S
    Infect Immun; 2007 Apr; 75(4):1916-25. PubMed ID: 17145948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional role of ompF and ompC porins in pathogenesis of avian pathogenic Escherichia coli.
    Hejair HMA; Zhu Y; Ma J; Zhang Y; Pan Z; Zhang W; Yao H
    Microb Pathog; 2017 Jun; 107():29-37. PubMed ID: 28315387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity in chickens with orally administered recombinant chicken-borne Lactobacillus saerimneri expressing FimA and OmpC antigen of O78 avian pathogenic Escherichia coli.
    Ma ST; Ding GJ; Huang XW; Wang ZW; Wang L; Yu ML; Shi W; Jiang YP; Tang LJ; Xu YG; Li YJ
    J Med Microbiol; 2018 Mar; 67(3):441-451. PubMed ID: 29458539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
    Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
    Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cloning, expression and immunity of pilA gene and ompC gene from avian pathogenic Escherichia coli].
    Yu S; Zhang Q; Shui X; Yu Z; Zhao B
    Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1561-7. PubMed ID: 19160838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First multi-epitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS).
    Wieser A; Magistro G; Nörenberg D; Hoffmann C; Schubert S
    Int J Med Microbiol; 2012 Jan; 302(1):10-8. PubMed ID: 22000741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides Affecting the Outer Membrane Lipid Asymmetry System (MlaA-OmpC/F) Reduce Avian Pathogenic Escherichia coli (APEC) Colonization in Chickens.
    Kathayat D; Closs G; Helmy YA; Lokesh D; Ranjit S; Rajashekara G
    Appl Environ Microbiol; 2021 Aug; 87(17):e0056721. PubMed ID: 34132592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed mutagenesis studies to probe the role of specific residues in the external loop (L3) of OmpF and OmpC porins in susceptibility of Serratia marcescens to antibiotics.
    Begic S; Worobec EA
    Can J Microbiol; 2007 Jun; 53(6):710-9. PubMed ID: 17668031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome analysis and in vivo virulence of porcine extraintestinal pathogenic Escherichia coli strain PCN033.
    Liu C; Zheng H; Yang M; Xu Z; Wang X; Wei L; Tang B; Liu F; Zhang Y; Ding Y; Tang X; Wu B; Johnson TJ; Chen H; Tan C
    BMC Genomics; 2015 Sep; 16(1):717. PubMed ID: 26391348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant outer membrane protein A induces a protective immune response against Escherichia coli infection in mice.
    Guan Q; Wang X; Wang X; Teng D; Mao R; Zhang Y; Wang J
    Appl Microbiol Biotechnol; 2015 Jul; 99(13):5451-60. PubMed ID: 25567514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis.
    Mellata M; Mitchell NM; Schödel F; Curtiss R; Pier GB
    Vaccine; 2016 Jan; 34(5):656-662. PubMed ID: 26707217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response.
    Secundino I; López-Macías C; Cervantes-Barragán L; Gil-Cruz C; Ríos-Sarabia N; Pastelin-Palacios R; Villasis-Keever MA; Becker I; Puente JL; Calva E; Isibasi A
    Immunology; 2006 Jan; 117(1):59-70. PubMed ID: 16423041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
    Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
    Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans.
    Turner AK; Terry TD; Sack DA; Londoño-Arcila P; Darsley MJ
    Infect Immun; 2001 Aug; 69(8):4969-79. PubMed ID: 11447175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice.
    Wieser A; Romann E; Magistro G; Hoffmann C; Nörenberg D; Weinert K; Schubert S
    Infect Immun; 2010 Aug; 78(8):3432-42. PubMed ID: 20498257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine.
    Russo TA; Beanan JM; Olson R; MacDonald U; Cope JJ
    Vaccine; 2009 Jan; 27(3):388-95. PubMed ID: 19014988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization of mice with plant-derived fimbrial adhesin FaeG induces systemic and mucosal K88ad enterotoxigenic Escherichia coli-specific immune responses.
    Liang W; Huang Y; Yang X; Zhou Z; Pan A; Qian B; Huang C; Chen J; Zhang D
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):393-9. PubMed ID: 16553813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.